Cargando...
Hypertrophic Obstructive Cardiomyopathy: The Role of Myectomy and Percutaneous Septal Ablation in Drug-refractory Disease
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%. METHODS: This review is based on publications retrieved by a selective literature search and on the authors’ clinical experience. RESULTS: 70% of patients with HCM suffer from t...
Guardado en:
| Publicado en: | Dtsch Arztebl Int |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Deutscher Arzte Verlag
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415619/ https://ncbi.nlm.nih.gov/pubmed/30855006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0047 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|